45.66
price down icon1.19%   -0.55
after-market 시간 외 거래: 46.76 1.10 +2.41%
loading
전일 마감가:
$46.21
열려 있는:
$45.03
하루 거래량:
761.77K
Relative Volume:
1.06
시가총액:
$1.74B
수익:
$17.39M
순이익/손실:
$-135.89M
주가수익비율:
-13.51
EPS:
-3.38
순현금흐름:
$-123.00M
1주 성능:
+4.08%
1개월 성능:
+34.73%
6개월 성능:
+23.91%
1년 성능:
+185.37%
1일 변동 폭
Value
$43.77
$47.06
1주일 범위
Value
$42.21
$48.60
52주 변동 폭
Value
$15.47
$48.60

Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile

Name
명칭
Tarsus Pharmaceuticals Inc
Name
전화
(949) 409-9820
Name
주소
15440 LAGUNA CANYON ROAD, IRVINE
Name
직원
244
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
TARS's Discussions on Twitter

Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-11-20 개시 Goldman Neutral
2023-07-18 개시 William Blair Outperform
2023-05-18 개시 Guggenheim Buy
2022-08-01 개시 Barclays Overweight
2021-12-21 개시 H.C. Wainwright Buy
2021-11-23 개시 Oppenheimer Outperform
2020-11-10 개시 BofA Securities Buy
2020-11-10 개시 Jefferies Buy
2020-11-10 개시 Ladenburg Thalmann Buy
2020-11-10 개시 Raymond James Strong Buy
모두보기

Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스

pulisher
04:26 AM

Tarsus Pharmaceuticals appoints new Chief Medical Officer - Investing.com

04:26 AM
pulisher
04:14 AM

Papulopustular Rosacea Market to Expand Significantly by 2034, States DelveInsight Report | Sol-Gel Technologies, Galderma, CollaGenex Pharma, Tarsus Pharma, Pfizer - Barchart

04:14 AM
pulisher
08:33 AM

Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer - GlobeNewswire

08:33 AM
pulisher
06:46 AM

Here's Why Tarsus Pharmaceuticals (NASDAQ:TARS) Can Manage Its Debt Despite Losing Money - Simply Wall St

06:46 AM
pulisher
03:51 AM

Vanguard Group Inc's Strategic Acquisition in Tarsus Pharmaceuti - GuruFocus.com

03:51 AM
pulisher
Nov 04, 2024

Emerald Mutual Fund Advisers Trust Acquires New Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Nov 04, 2024
pulisher
Nov 01, 2024

Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 8.5% HigherShould You Buy? - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains? - MSN

Nov 01, 2024
pulisher
Oct 30, 2024

Tarsus Pharmaceuticals stock hits 52-week high at $42.63 By Investing.com - Investing.com Australia

Oct 30, 2024
pulisher
Oct 29, 2024

Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 52-Week HighShould You Buy? - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Tarsus Pharmaceuticals stock hits 52-week high at $42.63 - Investing.com

Oct 29, 2024
pulisher
Oct 28, 2024

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap UpHere's Why - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Allspring Global Investments Holdings LLC Buys 29,465 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 28, 2024
pulisher
Oct 25, 2024

Assenagon Asset Management S.A. Raises Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 25, 2024
pulisher
Oct 17, 2024

Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY - The Bakersfield Californian

Oct 17, 2024
pulisher
Oct 17, 2024

Tarsus Launches “Your Mitey Problem,” the First - GlobeNewswire

Oct 17, 2024
pulisher
Oct 17, 2024

Tarsus Pharmaceuticals, Inc Announces the Launch of New Direct-To-Consumer TV campaign for XDEMVY - Marketscreener.com

Oct 17, 2024
pulisher
Oct 13, 2024

Essex Investment Management Co. LLC Invests $3.59 Million in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 13, 2024
pulisher
Oct 11, 2024

Was Tarsus Pharmaceuticals Inc (TARS)’s session last reading good? - US Post News

Oct 11, 2024
pulisher
Oct 11, 2024

Financial Analysis: Tarsus Pharmaceuticals Inc (TARS)’s Ratios Unveil Key Insights - The Dwinnex

Oct 11, 2024
pulisher
Oct 10, 2024

Taking a look at what insiders are doing to gauge the Tarsus Pharmaceuticals Inc (TARS)’s direction - Knox Daily

Oct 10, 2024
pulisher
Oct 10, 2024

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives $51.60 Consensus Price Target from Analysts - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Tarsus Pharmaceuticals Inc (TARS) Q2 2024 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Papulopustular Rosacea Market Revenue to Expand Significantly - openPR

Oct 09, 2024
pulisher
Oct 09, 2024

Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Path To Profitability - Simply Wall St

Oct 09, 2024
pulisher
Oct 09, 2024

Millennium Management LLC Raises Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 09, 2024
pulisher
Oct 07, 2024

Recent Insider Activity Suggests Potential Gains for Tarsus Pharmaceuticals Inc (TARS) - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Dimensional Fund Advisors LP Sells 17,931 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 07, 2024
pulisher
Oct 05, 2024

Healthcare of Ontario Pension Plan Trust Fund Decreases Stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 05, 2024
pulisher
Oct 04, 2024

Tarsus Pharmaceuticals (NASDAQ:TARS) versus Genocea Biosciences (NASDAQ:GNCA) Critical Contrast - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 5.3%Here's Why - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

(TARS) On The My Stocks Page - Stock Traders Daily

Oct 03, 2024
pulisher
Oct 01, 2024

Scientech Research LLC Invests $289,000 in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Tarsus Pharmaceuticals' SWOT analysis: stock surges on XDEMVY success - Investing.com

Oct 01, 2024
pulisher
Sep 30, 2024

Tarsus Pharmaceuticals' SWOT analysis: stock surges on XDEMVY success By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

Taking the lead: Tarsus Pharmaceuticals Inc (TARS) - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Driehaus Capital Management LLC Purchases 203,300 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Sep 30, 2024
pulisher
Sep 29, 2024

Frazier Life Sciences Management L.P. Reduces Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Sep 29, 2024
pulisher
Sep 27, 2024

Tarsus Pharmaceuticals Inc [TARS] Records 200-Day SMA of $29.59 - Knox Daily

Sep 27, 2024
pulisher
Sep 27, 2024

How did Tarsus Pharmaceuticals Inc (TARS) fare last session? - US Post News

Sep 27, 2024
pulisher
Sep 25, 2024

Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024 - ForexTV.com

Sep 25, 2024
pulisher
Sep 24, 2024

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Holdings Decreased by Ensign Peak Advisors Inc - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Tarsus Pharma maintains stock target on ECP feedback - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Federated Hermes Inc. Acquires 11,018 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Rhumbline Advisers Acquires 6,070 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Sep 22, 2024
pulisher
Sep 20, 2024

Tarsus Pharmaceuticals: Unlocking Growth Potential With Eye Care Innovations (NASDAQ:TARS) - Seeking Alpha

Sep 20, 2024
pulisher
Sep 20, 2024

Midday Stock Roundup: Staar Surgical Up - Orange County Business Journal

Sep 20, 2024
pulisher
Sep 20, 2024

Tarsus Pharmaceuticals Inc [TARS] Shares Jump Approximately 103.53% Over the Year - Knox Daily

Sep 20, 2024
pulisher
Sep 20, 2024

Tarsus Pharmaceuticals Inc (TARS) expanding its growth trajectory ahead - SETE News

Sep 20, 2024
pulisher
Sep 19, 2024

Trane Technologies (NYSE:TT) Sets New 52-Week High at $382.49 - MarketBeat

Sep 19, 2024

Tarsus Pharmaceuticals Inc (TARS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):